Hakutulokset - Floyd, John

RTHP-23. ADJUVANT THERAPY FOR HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA AFTER RTOG 9802: A SURVEY OF CURRENT PRACTICE Tekijä Fakhreddine, Mohamad, Parameswaran, Anand, Floyd, John, Brenner, Andrew, Crownover, Richard

Hae kokoteksti Hae kokoteksti

LMD-13. ReSPECT-LM: Maximum tolerated dose, safety, and efficacy of intraventricular Rhenium-186 Nanoliposome ((186)RNL) for leptomeningeal metastases Tekijä Brenner, Andrew, Floyd, John, Bao, Ande, Phillips, William, Stein, Gregory

Hae kokoteksti Hae kokoteksti

EVIDENCE THAT INSULIN RELEASE IS THE MECHANISM FOR EXPERIMENTALLY INDUCED LEUCINE HYPOGLYCEMIA IN MAN Tekijä Floyd, John C., Fajans, Stefan S., Knope, Ralph F., Conn, Jerome W.

Hae kokoteksti Hae kokoteksti

A Comparison of Leucine- and Acetoacetate-induced Hypoglycemia in Man Tekijä Fajans, Stefan S., Floyd, John C., Knopf, Ralph F., Conn, Jerome W.

Hae kokoteksti Hae kokoteksti

TRLS-08. CNS PENETRATION AND PRELIMINARY EFFICACY OF SACUTIZUMAB GOVITECAN IN BREAST BRAIN METASTASIS AND GLIOBLASTOMA: A SURGICAL STUDY Tekijä Brenner, Andrew, Floyd, John, Surapaneni, Prathiba, Madhusudanan-Kunnuparampil, Vinu, Tiziani, Stefano

Hae kokoteksti Hae kokoteksti

Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma Tekijä Blackmon, Melodie M, Gilbert, Andrea R, Floyd, John, Hafeez, Shaheryar, Seifi, Ali

Hae kokoteksti Hae kokoteksti Hae kokoteksti

THE EXPERIMENTAL INDUCTION IN MAN OF SENSITIVITY TO LEUCINE HYPOGLYCEMIA Tekijä Fajans, Stefan S., Knopf, Ralph F., Floyd, John C., Power, Lawrence, Conn, Jerome W.

Hae kokoteksti Hae kokoteksti

Oropharyngeal CSF Leak Secondary to Anterior Cervical Discectomy and Fusion Tekijä Weinheimer, Wyatt J., Rowley, Justin G., Otto, Randal, Floyd, John, Chen, Philip G.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience Tekijä Fountzilas, Christos, Chang, Katherine, Hernandez, Brian, Michalek, Joel, Crownover, Richard, Floyd, John, Mahalingam, Devalingam

Hae kokoteksti Hae kokoteksti Hae kokoteksti

RADT-24. HIGH ABSORBED DOSES OF RHENIUM-186 NANOLIPOSOMES (RNL) IN RECURRENT GBM: A PHASE 1 STUDY Tekijä Brenner, Andrew, Floyd, John, Bao, Ande, Phillips, William, Awasthi, Vibhudutta, Patel, Toral, Weinberg, Jeffrey

Hae kokoteksti Hae kokoteksti

AT-12 PHASE 1/2 STUDY OF TH-302, INVESTIGATIONAL HYPOXIA-ACTIVATED PRODRUG, AND BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA Tekijä Brenner, Andrew, Floyd, John, Eng, Clarence, Kroll, Stew, Fichtel, Lisa, Gruslova, Aleksandra, Lodi, Alessia, Tiziani, Stefano

Hae kokoteksti Hae kokoteksti

A Systematic Analysis of 2 Monoisocentric Techniques for the Treatment of Multiple Brain Metastases Tekijä Narayanasamy, Ganesh, Stathakis, Sotirios, Gutierrez, Alonso N., Pappas, Evangelos, Crownover, Richard, Floyd, John R., Papanikolaou, Niko

Hae kokoteksti Hae kokoteksti Hae kokoteksti

LMD-14. Preclinical safety and activity of intraventricular Rhenium-186 Nanoliposome ((186)RNL) for leptomeningeal metastases Tekijä Guerra-Garcia, Maria, Balinda, Henriette, Bao, Ande, Garcia, Michael, Gilbert, Andrea, Phillips, William, Floyd, John, Brenner, Andrew

Hae kokoteksti Hae kokoteksti

LOCL-04 SAFETY AND FEASIBILITY OF RHENIUM-186 NANOLIPOSOME (186RNL) IN LEPTOMENINGEAL METASTASES [LM] PHASE 1/2A DOSE ESCALATION TRIAL Tekijä Brenner, Andrew, Youssef, Michael, LaFrance, Norman, Hedrick, Marc, Bao, Ande, Phillips, William, Patel, Torel, Weinberg, Jeffrey, Floyd, John

Hae kokoteksti Hae kokoteksti

MNGI-11. TREATMENT OF MENINGIOMA WITH TH-302 IN A PDX MOUSE MODEL AND CELL LINE Tekijä Patel, Vaibhav, Maknojia, Asif, Garcia, Michael, Cavazos, David, Gruslova, Aleksandra, Courtney, Bosse, Papanikolaou, Niko, Kidane, Dawit, Brenner, Andrew, Floyd, John

Hae kokoteksti Hae kokoteksti

CTNI-07. DELIVERY AND ACTIVITY OF SN-38 BY SACITUZUMAB GOVITECAN IN CNS TUMORS Tekijä Brenner, Andrew, Floyd, John, Pandey, Renu, Chiou, Jennifer, Surapreneni, Prathiba, Kaklamani, Virginia, lathrop, Kate, Crownover, Richard, Caron, Jean Louis, Tiziani, Stefano

Hae kokoteksti Hae kokoteksti

Transcranial Direct Current Stimulation (tDCS) Can Alter Cortical Excitability of the Lower Extremity in Healthy Participants: A Review and Methodological Study. Tekijä Floyd, John Tyler, Lairamore, Chad, Garrision, Mark Kevin, Woods, Adam J., Rainey, Jacqueline L., Kiser, Thomas, Padala, Prasad R., Mennemeier, Mark

Hae kokoteksti Hae kokoteksti

Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma Tekijä Brenner, Andrew J., Floyd, John, Fichtel, Lisa, Michalek, Joel, Kanakia, Kunal P., Huang, Shiliang, Reardon, David, Wen, Patrick Y., Lee, Eudocia Quant

Hae kokoteksti Hae kokoteksti Hae kokoteksti

DD-02 PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA Tekijä Cavazos, David, Gruslova, Aleksandra, Sun, J., Floyd, John R., Fichtel, Lisa, Tadi, Surendar, Lodi, Alessia, Tiziani, Stefano, Hart, C.P., Eng, Clarence, Brenner, Andrew

Hae kokoteksti Hae kokoteksti

VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme Tekijä Gruslova, Aleksandra, Cavazos, David A, Miller, Jessica R., Breitbart, Eyal, Cohen, Yael C, Bangio, Livnat, Yakov, Niva, Soundararajan, Anu, Floyd, John R., Brenner, Andrew J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti